Autres langues Avalo Therapeutics, Inc.

Actions

AVTX

US05338F3064

Temps réel estimé Cboe BZX Autres places de cotation 21:37:50 16/05/2024			Varia. 5j.	Varia. 1 janv.
9,91 ^USD	-4,62 %		-11,44 %	+11,81 %

13/05	Avalo Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
16/04	AVALO THERAPEUTICS, INC. : Oppenheimer passe à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates	13/05
North American Morning Briefing : Stock Futures -2-	17/04
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors	02/04
Avalo Reports 2023 Financial Results and Provides Business Updates	01/04
Avalo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Avalo Reports 2023 Financial Results and Provides Business Updates	29/03
Sector Update: Health Care Stocks Rise Late Afternoon	28/03
Top Midday Gainers	28/03
Wall Street Set to Open Flat in Thursday Trading; Q4 US GDP Revised Up, Weekly Jobless Claims Fall	28/03
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	28/03
US Futures Little Changed Pre-Bell Thursday Ahead of Raft of Economic Data	28/03
Top Premarket Gainers	28/03
Avalo Therapeutics, Inc. announced that it has received $115.6 million in funding from Deep Track Capital, LP, TCG Crossover Management, LLC, BVF Partners L.P., RA Capital Management, L.P., Commodore Capital LP, Petrichor Holdings, LLC	28/03
Avalo Therapeutics, Inc. acquired AlmataBio, Inc. for $42.5 million.	28/03
Avalo Therapeutics Shares Triple After Acquisition of AlmataBio, Private Placement Financing of Up to $185 Million	27/03
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million	27/03
Avalo Therapeutics, Inc. Announces Board Appointments	27/03
North American Morning Briefing : Stocks Edge -2-	27/03
Avalo Therapeutics, Inc. announced that it expects to receive $115.6 million in funding from Deep Track Capital, LP, TCG Crossover Management, LLC, Commodore Capital, BVF Partners L.P., Petrichor Energy Inc., RA Capital Management, L.P.	27/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Avalo Therapeutics, Inc.

Actions

AVTX

US05338F3064

Autres langues

Filtres